Philippines Strengthens Drug Surveillance With Mandatory Import/Export Notification Rule
Executive Summary
The Philippines FDA explains how it intends to implement new requirements under which the import/export of each drug shipment will have to be notified by companies a month in advance.
You may also be interested in...
EU Group Facilitates Switching Multinational Trials To CTR
Revisions to the updated EU guideline on transitioning multinational trials to the Clinical Trials Regulation are said to be “solution oriented.”
EMA Addresses Rapid Acting Therapies, Psychedelics In Updated Guidance On Depression Treatments
The European Medicines Agency is consulting on major changes to its decade-old guidance on the development of medicinal products for acute and long-term treatment of major depressive disorder.
UK MHRA Gets A Grip On Spiralling Clinical Trial Assessment Timelines
The UK medicines regulator says the loss of experienced staff and the need to recruit and train new assessors resulted in temporary delays to clinical trial applications, but the crisis measures it put in place to address the situation mean it has now turned the corner.